Advances in cancer treatment showcased in London tube posters
Millions of commuters are being informed about an advance in radiotherapy that I helped pioneer.
Posters explaining the radiotherapy technique IMRT have appeared on London Underground stations.
It is part of a campaign by Cancer Research UK to raise awareness of new developments in treating cancer.
The poster tells how IMRT delivers a more precise and stronger dose of radiotherapy over a shorter course. The result is that patients make fewer trips to hospital and have fewer side effects.
It goes on to recount how a patient called David was diagnosed with prostate cancer in 2018 and began IMRT after treatment with hormone therapy.
The IMRT was completed in a month and was finished in time for David to take his family on a Christmas holiday.
It adds: “David’s treatment wouldn’t exist without research. Right now, your donations can help us to continue to develop better and kinder treatments.”
In collaboration with the Institute of Cancer Research, I was principal investigator in a series of trials that proved the effectiveness of IMRT in reducing potentially debilitating side-effects of the radiotherapy treatment for head and neck cancers.
Most recently I am involved in a new trial DARS which aims to improve swallowing after radiotherapy.
The success of the trials with IMRT were such that the Government awarded the Radiotherapy Innovation Fund £22 million to facilitate the adoption of the technology across the NHS. The technique has also been extended to many other forms of cancer, such as prostate.